Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome von Martinowich, Keri, Das, Debamitra, Sripathy, Srinidhi Rao, Mai, Yishan, Kenney, Rakaia F., Maher, Brady J.

Volltext

Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome von Bohlen, Joseph F, Cleary, Colin M, Das, Debamitra, Sripathy, Srinidhi Rao, Sadowski, Norah, Shim, Gina, Kenney, Rakaia F, Buchler, Ingrid P, Banerji, Tapasree, Scanlan, Thomas S, Mulkey, Daniel K, Maher, Brady J

Volltext

301. Pro-Myelinating Drugs Promote Functional Recovery in an ASD Mouse Model of Pitt-Hopkins Syndrome von Bohlen, Joseph, Cleary, Colin, Das, Debamitra, Sripathy, Srinidhi Rao, Sadowski, Norah, Shim, Gina, Kenney, Rakaia, Buchler, Ingrid, Banerji, Tapasree, Scanlan, Thomas, Mulkey, Daniel, Maher, Brady

Volltext

Evaluation of Na v 1.8 as a therapeutic target for Pitt Hopkins Syndrome von Martinowich, Keri, Das, Debamitra, Sripathy, Srinidhi Rao, Mai, Yishan, Kenney, Rakaia F, Maher, Brady J

Volltext